Identiv, Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Identiv, Inc. filed its Q1 2024 10-Q, detailing financial performance, balance sheet items, and stock-based compensation.</b>

AI Summary

Identiv, Inc. (INVE) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Identiv, Inc. reported financial results for the quarter ended March 31, 2024. The filing includes data related to various expense categories such as Cost of Sales, General and Administrative Expense, Selling and Marketing Expense, and Employee Severance. Key balance sheet items like Additional Paid In Capital, Accumulated Other Comprehensive Income, Retained Earnings, and Treasury Stock are detailed. Information on stock-based compensation, including Stock Options and Restricted Stock Units, is provided for the periods ending March 31, 2023, and March 31, 2024. The company's financial structure is further detailed with references to Series B Convertible Preferred Stock and its associated common stock issuances.

Why It Matters

For investors and stakeholders tracking Identiv, Inc., this filing contains several important signals. This 10-Q filing provides a detailed look at Identiv's financial health and operational expenses for the first quarter of 2024, crucial for investors assessing performance trends. The inclusion of specific data on revenue segments, expenses, and equity components offers transparency into the company's financial position and strategic resource allocation.

Risk Assessment

Risk Level: medium — Identiv, Inc. shows moderate risk based on this filing. The filing contains numerous financial and operational data points, requiring careful analysis to fully understand the company's current standing and future prospects, which could indicate medium risk for investors relying solely on this document.

Analyst Insight

Investors should analyze the detailed expense breakdowns and revenue segment performance to identify key drivers of profitability and potential areas for improvement.

Key Numbers

• 2024-03-31 — Reporting Period End Date (10-Q Filing)
• 2024-05-10 — Filing Date (10-Q Filing)
• 2023-01-01 to 2023-03-31 — Prior Year Q1 Period (Comparative Financial Data)
• 2024-01-01 to 2024-03-31 — Current Year Q1 Period (Financial Data)

Key Players & Entities

• Identiv, Inc. (company) — Filer
• INVE (company) — Ticker Symbol
• 2024-03-31 (date) — Reporting Period End Date
• 2024-05-10 (date) — Filing Date
• EastWest Bank (company) — Lender in Revolving Credit Facility
• Series B Convertible Preferred Stock (dollar_amount) — Type of Preferred Stock

FAQ

Industry Context

Identiv operates in the technology sector, focusing on identity verification, security, and access control solutions.

Regulatory Implications

The company is subject to standard SEC reporting requirements for public companies, including quarterly 10-Q filings.

What Investors Should Do

1. Review detailed segment revenues and cost of sales for Q1 2024.
2. Analyze changes in operating expenses compared to the prior year's Q1.
3. Examine the components of equity and debt as presented in the balance sheet.

Year-Over-Year Comparison

This filing represents the quarterly report for the period ending March 31, 2024, following the previous annual report (10-K) and prior quarterly filings.

Key Financial Figures

• $0.001 — nge on which registered Common Stock, $0.001 par value per share INVE The Nasdaq

Filing Documents

• inve-20240331.htm (10-Q) — 1811KB
• inve-ex31_1.htm (EX-31.1) — 14KB
• inve-ex31_2.htm (EX-31.2) — 14KB
• inve-ex32.htm (EX-32) — 12KB
• 0000950170-24-057322.txt (&nbsp;) — 8726KB
• inve-20240331.xsd (EX-101.SCH) — 1340KB
• inve-20240331_htm.xml (XML) — 1616KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited) 3 Condensed Consolidated Balance Sheets 3 Condensed Consolidated Statements of Comprehensive Loss 4 Condensed Consolidated Statements of Stockholders' Equity 5 Condensed Consolidated Statements of Cash Flows 6 Notes to Unaudited Condensed Consolidated Financial Statements 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 22 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 32 Item 4.

Controls and Procedures

Controls and Procedures 32

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 34 Item 1A.

Risk Factors

Risk Factors 34 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 40 Item 5. Other Information Item 6. Exhibits 41

: FINANCIAL INFORMATION

PART I: FINANCIAL INFORMATION

Fin ancial Statements

Item 1. Fin ancial Statements IDENTIV, INC. CONDENSED CONSOLIDA TED BALANCE SHEETS (Unaudited, in thousands, except par value) March 31, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 21,623 $ 23,312 Restricted cash 811 1,072 Accounts receivable, net of allowances of $ 701 and $ 2,627 as of March 31, 2024 and December 31, 2023, respectively 17,811 21,969 Inventories 28,460 28,712 Prepaid expenses and other current assets 4,159 4,421 Total current assets 72,864 79,486 Property and equipment, net 8,832 9,320 Operating lease right-of-use assets 4,756 5,214 Intangible assets, net 3,995 4,251 Goodwill 10,192 10,218 Other assets 1,150 1,234 Total assets $ 101,789 $ 109,723 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 9,564 $ 12,250 Financial liabilities, net of debt issuance costs of $ 106 and $ 51 as of March 31, 2024 and December 31, 2023, respectively 9,894 9,949 Operating lease liabilities 1,655 1,714 Deferred revenue 1,744 2,341 Accrued compensation and related benefits 2,099 2,334 Other accrued expenses and liabilities 2,351 2,194 Total current liabilities 27,307 30,782 Long-term operating lease liabilities 3,309 3,716 Long-term deferred revenue 981 927 Other long-term liabilities 26 26 Total liabilities 31,623 35,451 Commitments and contingencies (see Note 15) Stockholders' equity: Preferred stock, $ 0.001 par value: 10,000 shares authorized; 5,000 shares issued and outstanding as of March 31, 2024 and December 31, 2023 5 5 Common stock, $ 0.001 par value: 50,000 shares authorized; 25,022 and 24,902 shares issued and 23,334 and 23,247 shares outstanding as of March 31, 2024 and December 31, 2023, respectively 25 25 Additional paid-in capital 501,771 500,752 Treasury stock, 1,688 and 1,655 shares as of March 31, 2024

View Full Filing

View this 10-Q filing on SEC EDGAR